HCW Biologics (HCWB) EPS (Basic) (QoQ) (2020 - 2025)
HCW Biologics (HCWB) EPS (Basic) (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.70 Bn | 131.85 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.36 Bn | 60.18 Bn | 1.37 Bn |
| 4 | Moderna | 59.15 Bn | 54.01 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.88 Bn | 28.57 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - |
| 10 | HCW Biologics | 2.87 Mn | 2.13 Mn | -93,887.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18.01% |
| Sep 30, 2025 | 70.31% |
| Jun 30, 2025 | -13,548.16% |
| Mar 31, 2025 | 98.57% |
| Dec 31, 2024 | 15.72% |
| Sep 30, 2024 | 74.46% |
| Jun 30, 2024 | -100.67% |
| Mar 31, 2024 | 32.82% |
| Dec 31, 2023 | -56.53% |
| Sep 30, 2023 | -8.94% |
| Jun 30, 2023 | -15.62% |
| Mar 31, 2023 | 5.50% |
| Dec 31, 2022 | -37.53% |
| Sep 30, 2022 | -19.31% |
| Jun 30, 2022 | -70.47% |
| Mar 31, 2022 | 65.99% |
| Dec 31, 2021 | -22.10% |
| Sep 30, 2021 | 78.92% |
| Jun 30, 2021 | 4.27% |
| Mar 31, 2021 | -299.34% |